85 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
23
New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation.
Universities of Lille
47
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Jagiellonian University Medical College
38
Tactical Approaches to Interconverting GPCR Agonists and Antagonists.
University of Minnesota
20
Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
University of Lille
16
Synthesis of 2-arylfuro[3,2-b]pyridines: Effect of the C2-aryl group on melatoninergic activity.
Orleans University
2
New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.
IQM-CSIC
22
Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential.
IQM-CSIC
26
Efficient synthesis of hexahydroindenopyridines and their potential as melatoninergic ligands.
Universidad De Valencia
29
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
The German University In Cairo
6
Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT(2)-selective melatonin agonists: improving metabolic stability.
Hong Kong University of Science and Technology
15
Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors.
Paris-Sud University
11
Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.
University of Urbino
32
Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
University of Bari Aldo Moro
19
Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.
University of Lille
39
Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
King'S College London
6
Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.
Orleans University
13
Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.
Takeda Pharmaceutical
9
Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.
University of Lille
21
1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT2-selective agonists.
Takeda Pharmaceutical
11
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
University of Lille
16
Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists.
Orleans University
21
Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.
Merck Research Laboratories
22
Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands.
Hong Kong University of Science and Technology
4
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
University of W£Rzburg
6
Synthesis and receptor binding studies of quinolinic derivatives as melatonin receptor ligands
TBA
21
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
University of WüRzburg
21
Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
University of Lille 2
7
Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.
University of WüRzburg
16
Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.
Université
32
The location, physiology, pathology of hippocampus Melatonin MT2 receptor and MT2-selective modulators.
The First Affiliated Hospital of China Medical University
4
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT
University of Urbino Carlo Bo
8
2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design.
Shanghaitech University
8
Natural spirocyclic alkaloids and polyphenols as multi target dementia leads.
Rmit University
3
Recent research progress of Uncaria spp. based on alkaloids: phytochemistry, pharmacology and structural chemistry.
China Pharmaceutical University
33
Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
University of Athens
5
Design and Validation of the First Family of Photo-Activatable Ligands for Melatonin Receptors.
University of Paris
11
Synthesis and biological evaluation of paeoveitol D derivatives as new melatonin receptor agonists with antidepressant activities.
Chinese Academy of Sciences
14
(R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents.
Bristol Myers Squibb
29
Tetrahydroisoquinoline derivatives as melatonin MT2 receptor antagonists.
Bristol Myers Squibb
19
N-[2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl]acetamide: an orally bioavailable melatonin receptor agonist.
Bristol Myers Squibb
39
Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.
Bristol Myers Squibb
38
4-Substituted anilides as selective melatonin MT2 receptor agonists.
Bristol Myers Squibb
20
Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist.
Takeda Pharmaceutical
24
Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.
Bristol Myers Squibb
20
Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.
Bristol Myers Squibb
22
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties.
IQM-CSIC
9
Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.
Université
2
Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.
Takeda Chemical Industries
35
Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.
Institut De Chimie Pharmaceutique Albert Lespagnol
12
Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).
Institut De Chimie Pharmaceutique Albert Lespagnol
15
Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine.
Umr-S1172 - Jparc - Centre De Recherche Jean-Pierre Aubert Neurosciences Et Cancer
43
Design and Discovery of Functionally Selective Serotonin 2C (5-HT
University of Illinois At Chicago
38
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.
Paris-Sud University
4
Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).
Icahn School Of Medicine At Mount Sinai
2
Polybenzyls from Gastrodia elata, their agonistic effects on melatonin receptors and structure-activity relationships.
Chinese Academy of Sciences
15
Synthesis of benzocycloalkane derivatives as new conformationally restricted ligands for melatonin receptors.
Paris-Sud University
4
Development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors.
Duquesne University
12
Indole-based melatonin analogues: Synthetic approaches and biological activity.
Nantong University
4
Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin Neurohormone.
Orleans University
16
N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
University of Parma
19
7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity.
University College London
11
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.
University of Parma
13
Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
University of Milan
4
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
University of Parma
27
2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.
University of Urbino
1
Generally applicable, convenient solid-phase synthesis and receptor affinities of octreotide analogs.
Washington University School of Medicine
1
Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.
Chinese Academy of Sciences
26
Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT
Univ. Lille
17
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit.
University of Urbino
12
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands.
University of Parma
121
Monoacylglycerol lipase modulators for use in autism spectrum disorders
Janssen Pharmaceutica
12
The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines.
Polish Academy of Sciences
6
Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue.
Universite De Lyon